News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
678,678 Results
Type
Article (52197)
Company Profile (250)
Press Release (626231)
Section
Business (191693)
Career Advice (2621)
Deals (34161)
Drug Delivery (116)
Drug Development (79058)
Employer Resources (160)
FDA (16307)
Job Trends (15198)
News (329993)
Policy (32621)
Tag
Academia (2849)
Alliances (49552)
Alzheimer's disease (1400)
Approvals (16276)
Artificial intelligence (228)
Bankruptcy (343)
Best Places to Work (11960)
Biotechnology (160)
Breast cancer (233)
Cancer (1815)
Cardiovascular disease (146)
Career advice (2204)
CAR-T (137)
Cell therapy (388)
Clinical research (63733)
Collaboration (728)
Compensation (334)
COVID-19 (2668)
C-suite (181)
Data (1708)
Diabetes (227)
Diagnostics (6556)
Earnings (70350)
Employer resources (143)
Events (100837)
Executive appointments (615)
FDA (17281)
Funding (639)
Gene therapy (273)
GLP-1 (728)
Government (4691)
Healthcare (19555)
Infectious disease (2793)
Inflammatory bowel disease (132)
Interviews (539)
IPO (15531)
Job creations (3709)
Job search strategy (1820)
Layoffs (453)
Legal (7432)
Lung cancer (270)
Manufacturing (255)
Medical device (14268)
Medtech (14272)
Mergers & acquisitions (19032)
Metabolic disorders (606)
Neuroscience (1858)
NextGen: Class of 2025 (6955)
Non-profit (4856)
Northern California (2065)
Obesity (328)
Opinion (231)
Patents (177)
People (58917)
Phase I (19702)
Phase II (27986)
Phase III (21213)
Pipeline (789)
Postmarket research (2590)
Preclinical (8141)
Radiopharmaceuticals (251)
Rare diseases (342)
Real estate (6059)
Regulatory (22359)
Research institute (2523)
Resumes & cover letters (388)
Southern California (1822)
Startups (3649)
United States (18844)
Vaccines (644)
Weight loss (241)
Date
Today (61)
Last 7 days (828)
Last 30 days (2653)
Last 365 days (34602)
2025 (5377)
2024 (35490)
2023 (40170)
2022 (51197)
2021 (55616)
2020 (54647)
2019 (48713)
2018 (37042)
2017 (33069)
2016 (32400)
2015 (37580)
2014 (29511)
2013 (24958)
2012 (26905)
2011 (27586)
2010 (25502)
Location
Africa (869)
Arizona (192)
Asia (40613)
Australia (7618)
California (4769)
Canada (1739)
China (420)
Colorado (226)
Connecticut (240)
Europe (91890)
Florida (728)
Georgia (179)
Illinois (501)
Indiana (285)
Maryland (787)
Massachusetts (3595)
Michigan (204)
Minnesota (342)
New Jersey (1393)
New York (1389)
North Carolina (895)
Northern California (2065)
Ohio (184)
Pennsylvania (1092)
South America (1211)
Southern California (1822)
Texas (711)
Utah (156)
Washington State (459)
678,678 Results for "pure bioscience formerly known as innovative medical services".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
PURE Bioscience Announces a New Distribution Agreement With Hydrite Chemical Company
January 21, 2025
·
6 min read
Business
PURE Bioscience Reports Fiscal Third Quarter 2024 Financial Results
PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for the fiscal third quarter ended April 30, 2024.
June 14, 2024
·
12 min read
Business
PURE Bioscience Appoints Darin Zehr to Board of Directors
PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported the appointment of Darin Zehr to its Board of Directors, effective as of May 1, 2024.
May 6, 2024
·
4 min read
Press Releases
PURE Bioscience Reports Fiscal First Quarter 2025 Financial Results
December 16, 2024
·
8 min read
Press Releases
Averna Therapeutics, formerly known as Exsilio Therapeutics, Appoints Thomas M. Barnes, Ph.D., as Chief Executive Officer
January 27, 2025
·
3 min read
Press Releases
PURE Bioscience Announces Distribution Agreement with Quip Laboratories
November 4, 2024
·
5 min read
Business
PURE Bioscience Announces an International Supply and License Agreement with AgroVet Alliance
PURE Bioscience, Inc., creator of the patented non-toxic silver dihydrogen citrate antimicrobial, and AgroVet Alliance, FZE, have entered into a multi-year international supply and license agreement for the purchase and selling of SDC products under special terms and conditions.
June 18, 2024
·
6 min read
Press Releases
PURE Bioscience Reports Fiscal 2024 Financial Results
October 29, 2024
·
10 min read
Business
PURE Bioscience Reports Fiscal Second Quarter 2024 Financial Results
PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for the fiscal second quarter ended January 31, 2024.
March 18, 2024
·
13 min read
Press Releases
PURE Bioscience Announces Distribution Agreement with Madison Chemical Co., Inc.
October 23, 2024
·
6 min read
1 of 67,868
Next
